Completed
An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive
NCT00000721
- Conditions
- AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
- Locations
-
- Stanford CRS Palo Alto, California, United States